2nd Annual Gene Therapy Medical Affairs
Evvnt Promotion / evvnt
19.04.2022 - 21.04.2022 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, USA
Time: 08:00 - 18:00
Conference themes
The 2nd Gene Therapy Medical Affairs Summit is dedicated to exploring the pivotal internal and external role Medical Affairs plays in delivering gene therapies to patients.
Whilst Gene Therapies are set to transform treatment paradigms, their complex nature and high price tag presents unique challenges.
The 2nd Gene Therapy Medical Affairs Summit is dedicated to exploring the pivotal internal and external role Medical Affairs plays in delivering gene therapies to patients.
Whilst Gene Therapies are set to transform treatment paradigms, their complex nature and high price tag presents unique challenges.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Speakers: Kent Christopherson, Senior Director US Medical Affairs, Orchard Therapeutics, Ian Winburn, Global Medical Lead Haemophillia, Pfizer, Alexis Russell, Senior Director, US Gene Therapy, Therapeutic Area Lead PTC Therapeutics and more.
Speakers: Kent Christopherson, Senior Director US Medical Affairs, Orchard Therapeutics, Ian Winburn, Global Medical Lead Haemophillia, Pfizer, Alexis Russell, Senior Director, US Gene Therapy, Therapeutic Area Lead PTC Therapeutics and more.
Enquiries and Registration:
https://go.evvnt.com/962696-2?pid=4832
Ms. Emily Lincoln
General Medicine
Languages
English
English
Congress fees
Conference + 3 Workshops: USD 4946.0, Conference + 2 Workshops: USD 4297.0, Conference + 1 Workshop: USD 3648.0, Conference Only: USD 2999.0
Conference + 3 Workshops: USD 4946.0, Conference + 2 Workshops: USD 4297.0, Conference + 1 Workshop: USD 3648.0, Conference Only: USD 2999.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
